JNJ - JOHNSON & JOHNSON
207.78
2.000 0.963%
Share volume: 2,376,541
Last Updated: 12-24-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$205.78
2.00
0.01%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-29-2024 | 12-29-2024 | 03-30-2025 | 06-29-2025 | 09-28-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 02-13-2025 | 05-01-2024 | 07-25-2024 | 10-23-2024 | 02-13-2025 | 04-23-2025 | 07-24-2025 | 10-22-2025 | |
| Assets | |||||||||
| Total Assets | 167.558 B | 171.966 B | 181.088 B | 178.287 B | 180.104 B | 193.671 B | 193.389 B | 192.816 B | |
| Current Assets | 53.495 B | 57.002 B | 57.817 B | 53.249 B | 55.893 B | 71.551 B | 54.498 B | 54.611 B | |
| Inventories | 11.181 B | 11.383 B | 12.169 B | 12.603 B | 12.444 B | 12.659 B | 13.412 B | 14.146 B | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 1.068 B | 745.000 M | 597.000 M | 317.000 M | 417.000 M | 307.000 M | 303.000 M | 331.000 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 21.859 B | 25.473 B | 24.878 B | 19.980 B | 24.105 B | 38.474 B | 18.577 B | 18.231 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 19.898 B | 19.632 B | 19.748 B | 20.479 B | 20.518 B | 20.871 B | 21.949 B | 22.338 B | |
| Other Assets | 94.165 B | 95.332 B | 103.523 B | 104.559 B | 103.693 B | 101.249 B | 116.942 B | 115.867 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 167.558 B | 171.966 B | 181.088 B | 178.287 B | 180.104 B | 193.671 B | 193.389 B | 192.816 B | |
| Total liabilities | 98.784 B | 101.946 B | 109.550 B | 108.129 B | 108.614 B | 115.562 B | 114.916 B | 113.539 B | |
| Total current liabilities | 46.282 B | 48.725 B | 53.933 B | 51.759 B | 50.321 B | 56.903 B | 54.180 B | 50.869 B | |
| Accounts Payable | 9.632 B | 8.174 B | 8.848 B | 8.954 B | 10.311 B | 9.545 B | 9.464 B | 9.625 B | |
| Other liabilities | 13.398 B | 15.067 B | 14.086 B | 14.923 B | 17.549 B | 10.435 B | 10.263 B | 9.926 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 25.881 B | 25.082 B | 31.636 B | 31.289 B | 30.651 B | 38.355 B | 39.235 B | 39.408 B | |
| Other liabilities | 13.398 B | 15.067 B | 14.086 B | 14.923 B | 17.549 B | 10.435 B | 10.263 B | 9.926 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 68.774 B | 70.020 B | 71.538 B | 70.158 B | 71.490 B | 78.109 B | 78.473 B | 79.277 B | |
| Common stock | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | |
| Retained earnings | 153.843 B | 153.378 B | 155.360 B | 155.179 B | 155.791 B | 162.635 B | 165.371 B | 167.281 B |